头帕肿瘤综合征蛋白与肿瘤坏死因子受体介导的坏死样凋亡
作者: |
1田静,
2王玉霞,
1彭军
1 中南大学药学院药理学系,长沙 410078 2 常德职业技术学院药学系,湖南 常德 415000 |
通讯: |
彭军
Email: junpeng@csu.edu.cn |
DOI: | 10.3978/j.issn.2095-6959.2016.04.025 |
基金: | 国家自然科学基金项目资助, 91439104; 81373409 |
摘要
头帕肿瘤综合征蛋白(cylindromatosis,CYLD)是一种去泛素化酶,其C-末端USP结构域具有催化功能,可移除受体相互作用蛋白激酶1(receptor interacting protein kinase 1,RIPK1)的K63连接泛素链,调节RIPK1的泛素化水平,从而参与调节肿瘤坏死因子受体1(tumor necrosis factor receptor 1,TNFR1)介导的RIPK依赖的细胞坏死样凋亡等病理生理过程。阐明CYLD对RIPK1去泛素化调节的详细机制,寻找针对CYLD的特异性抑制剂,可为与坏死样凋亡相关的损伤与疾病提供治疗的新策略。
关键词:
CYLD
去泛素化
坏死样凋亡
受体相互作用蛋白激酶
肿瘤坏死因子受体1
CYLD and tumor necrosis factor receptor-mediated necroptosis
CorrespondingAuthor: PENG Jun Email: junpeng@csu.edu.cn
DOI: 10.3978/j.issn.2095-6959.2016.04.025
Abstract
Cylindromatosis (CYLD) is a deubiquitinase, which regulates the level of ubiquitination for receptor interacting protein kinase 1 (RIPK1) by removing lysine 63-linked polyubiquitin chains. CYLD involves in the regulation of RIPK-dependent and tumor necrosis factor receptor 1 (TNFR1)-mediated cell necroptosis and other physiological and pathological processes. Clarification of the detailed mechanism of CYLD on RIPK1 and identification of specific inhibitor of this process will provide a new strategy for the treatment of the diseases associated with necroptosis.